))
51: Jorge Santos da Silva: Visão de CEO de startup biotecnológica
Manage episode 344490124 series 3381015
Вміст надано André Correia e Daniel Guedelha, André Correia, and Daniel Guedelha. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією André Correia e Daniel Guedelha, André Correia, and Daniel Guedelha або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Neste episódio do Podcast CRUZAMENTO, André Correia e Daniel Guedelha conversam com Jorge Santos da Silva, Fundador e CEO da MoonLake Immunotherapeutics sobre biotech, investimentos e inovação e, sobre como Portugal é visto por alguém com uma grande experiência internacional.
Jorge Santos da Silva, is a co-Founder of MoonLake and has served as the Chief Executive Officer of MoonLake since July 2021, being also a Director of the Board. Prior to MoonLake, he was at McKinsey & Company, Inc. from September 2007 to June 2021, where he was a Senior Partner and led the Pharmaceutical & Medical Products Practice, the Biotech group and the Biosimilars group and advised international biopharmaceutical and biotechnology companies on corporate and business-unit strategy, commercial operating models, R&D, organizational design, M&A and joint ventures. Dr. Santos da Silva was a Postdoctoral Fellow at Cold Spring Harbor Laboratory, NY (USA) and holds a Ph.D. in Neuronal Cell Biology from the University of Turin (Italy) and a MSc in Molecular Biology from the University of Glasgow — Institute of Biological and Life Sciences (United Kingdom) and the European Molecular Biology Laboratory, Heidelberg (Germany). He is also a professor and Board Advisor at the School of Medicine at the Minho University in Portugal.
Outras referências feitas no episódio:
Contactos:
86 епізодів
Поширити
